Search company, investor...

NeuroLife Noninvasive Solutions

neurolifemed.com

Stage

Unattributed VC - II | Alive

Total Raised

$350K

Last Raised

$250K | 16 yrs ago

About NeuroLife Noninvasive Solutions

NeuroLife Noninvasive Solutions offers Surgical and medical Instruments and apparatus

Headquarters Location

700 River Avenue, Suite 232

Pittsburgh, Pennsylvania, 15212,

United States

Missing: NeuroLife Noninvasive Solutions's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: NeuroLife Noninvasive Solutions's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

NeuroLife Noninvasive Solutions Frequently Asked Questions (FAQ)

  • Where is NeuroLife Noninvasive Solutions's headquarters?

    NeuroLife Noninvasive Solutions's headquarters is located at 700 River Avenue, Suite 232, Pittsburgh.

  • What is NeuroLife Noninvasive Solutions's latest funding round?

    NeuroLife Noninvasive Solutions's latest funding round is Unattributed VC - II.

  • How much did NeuroLife Noninvasive Solutions raise?

    NeuroLife Noninvasive Solutions raised a total of $350K.

  • Who are the investors of NeuroLife Noninvasive Solutions?

    Investors of NeuroLife Noninvasive Solutions include Pittsburgh Life Sciences Greenhouse and Riverside Center for Innovation.

  • Who are NeuroLife Noninvasive Solutions's competitors?

    Competitors of NeuroLife Noninvasive Solutions include Paragon Medical, Cambridge Endoscopic Devices, Asensus Surgical, iScience Interventional, Starion Instruments and 13 more.

Compare NeuroLife Noninvasive Solutions to Competitors

A
Advanced Surgical Concepts

Advanced Surgical Concepts develops surgical instruments for use in endoscopy and in minimally invasive surgery

C
Clear View Endoscopy

Clear View Endoscopy is an endoscope repair facility.

A
Axis Surgical Technologies

Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment. Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.

TransCorp Logo
TransCorp

TransCorp develops and commercializes minimally invasive surgical instruments and implants for neurosurgical and orthopedic applications.

C
Clearmedical

ClearMedical is a distributor of remanufactured brand name surgical devices. ClearMedical aims to drive cost savings by selling high-volume, disposable, FDA approved laparoscopic, arthroscopic, and general surgical devices at reduced prices. The company collects used Single-Use-Devices (SUDs) from hospitals, reprocesses them consistent with FDA approvals, and sells them to hospitals and surgery centers wanting to reduce supply acquisition costs. The company's device list includes harmonic scalpels from Ethicon, trocars from Ethicon, US Surgical (AutoSuture), laparoscopic instruments from Ethicon, US Surgical (AutoSuture), clip appliers from ethicon, US Surgical (AutoSuture), linear cutter and staplers from Ethicon, and bone shavers from Linvatec, Smith & Nephew, and Stryker.

N
Neurosonix

NeuroSonix is an Israeli medical device company targeting the market of cerebral embolic protection during cardiac surgical and other minimally invasive procedures. NeuroSonix has conceived, developed and patented a technology and medical devices for the prevention of acute cerebral embolism during open-heart cardiac surgery as well as other invasive and minimally-invasive procedures. The company's technology, which is based on ultrasound, aims to enable a non-invasive deflection of embolic material flowing inside the body, away from the cerebral arteries. This new ultrasonic modality aims to reduce the embolic load on the patient's brain. The first product developed by the company is the EmBlocker"ž, intended to provide protection from acute cerebral embolism during cardiac surgical procedures. The Protection Collar, the company's second product, is intended for embolic protection during minimally-invasive procedures and Cath-lab practice.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.